| Followers | 0 |
| Posts | 41 |
| Boards Moderated | 0 |
| Alias Born | 02/22/2026 |
Tuesday, February 24, 2026 12:05:35 PM
Cannabis isn’t just talk — it’s already real medicine. In 2018, the FDA approved Epidiolex, a drug made from cannabis, to treat severe seizures. That means a part of the plant passed strict safety and testing rules, just like other prescription drugs. Big science reports say cannabis helps adults with long-term pain, nerve pain, and nausea from cancer treatment. This isn’t hype — it’s published research.
Your body even has a built-in system designed to respond to cannabis, called the endocannabinoid system. It helps control pain, swelling, mood, and balance. So cannabis isn’t some random substance — it works with systems your body already has.
Millions of patients already use medical cannabis in over 30 states. The demand is real. If cannabis moves to Schedule III, it would look less risky under federal law. Less risk usually makes big investors more comfortable. And when more investors step in, cannabis stocks can gain attention — and potentially rise.
The medicine exists. The science exists. The patients exist. Now policy just has to catch up.
Your body even has a built-in system designed to respond to cannabis, called the endocannabinoid system. It helps control pain, swelling, mood, and balance. So cannabis isn’t some random substance — it works with systems your body already has.
Millions of patients already use medical cannabis in over 30 states. The demand is real. If cannabis moves to Schedule III, it would look less risky under federal law. Less risk usually makes big investors more comfortable. And when more investors step in, cannabis stocks can gain attention — and potentially rise.
The medicine exists. The science exists. The patients exist. Now policy just has to catch up.
Bullish
Recent SNDL News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 08:35:07 PM
- SNDL to Report First Quarter 2026 Financial Results on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 08:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 09:35:45 PM
- SNDL Announces Leadership Transition for Cannabis Segment • GlobeNewswire Inc. • 03/30/2026 09:00:00 PM
- SNDL shares climb over 4% despite fourth-quarter revenue miss • IH Market News • 03/12/2026 02:01:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/12/2026 10:55:05 AM
- SNDL Reports Fourth Quarter and Full Year 2025 Financial and Operational Results • GlobeNewswire Inc. • 03/12/2026 10:55:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/19/2026 09:40:03 PM
- SNDL to Report Fourth Quarter 2025 and Full Year 2025 Financial Results on March 12, 2026 • GlobeNewswire Inc. • 02/19/2026 09:30:00 PM
- SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan • Newsfile • 01/07/2026 09:43:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/07/2026 09:32:18 PM
- SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan • GlobeNewswire Inc. • 01/07/2026 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/15/2025 09:36:51 PM
- SNDL & 1CM Provide Update Regarding Arrangement • GlobeNewswire Inc. • 12/15/2025 09:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/13/2025 02:25:03 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/21/2025 09:35:03 PM
- SNDL Announces Renewal of Share Repurchase Program • GlobeNewswire Inc. • 11/21/2025 09:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/04/2025 12:05:03 PM
- SNDL Reports Third Quarter 2025 Financial and Operational Results • GlobeNewswire Inc. • 11/04/2025 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/30/2025 12:52:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/15/2025 08:46:02 PM
- SNDL to Announce Third Quarter 2025 Financial Results on November 4, 2025 • GlobeNewswire Inc. • 10/15/2025 08:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/01/2025 08:30:23 PM
